Skip to main content
SpringerLink
Log in

H1 antagonists: receptor affinity versus selectivity

  • Regular paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. UCB Pharma Sector, In Vitro Pharmacology, Chemin Du Foriest, 1420 Braine l'Alleud, Belgium, Fax: ++ 32 2 386 33 97, e-mail: michel.gillard@ucb-group.com , , , , , , BE

    M. Gillard, B. Christophe, M. Peck, R. Massingham & P. Chatelain

  2. UCB Research Inc., Cambridge, Ma, USA, , , , , , US

    B. Wels

Authors
  1. M. Gillard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Christophe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Wels
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Peck
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Massingham
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Chatelain
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

RID="*"

ID="*"Corrspondence to: M. Gillard

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gillard, M., Christophe, B., Wels, B. et al. H1 antagonists: receptor affinity versus selectivity. Inflamm. res. 52 (Suppl 1), s49–s50 (2003). https://doi.org/10.1007/s000110300050

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s000110300050

Keywords

Search

Navigation